Annovis BioAdvance News Portfolio News

Annovis Bio Announces Positive Results from NIH Funded Chronic Toxicology Study

By WebmasterJune 16, 2020November 1st, 2024No Comments

Annovis Bio Announces Positive Results from NIH Funded Chronic Toxicology Study

Previous PostMelior Discovery Announces Partnership with SFA on Grant Directed to COVID-19
Next PostENB Therapeutics Announces Successful Completion of the First Dosing Cohort in Phase I Clinical Trial of ENB-003 in Combination with Pembrolizumab